CM
TMO icon

Capula Management’s Thermo Fisher Scientific TMO Stock Holding History

Capula Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Sell
600
-500
-45% -$240K ﹤0.01% 477
2026
Q1 		$541K Buy
1,100
+200
+22% +$109K ﹤0.01% 501
2025
Q4 		$522K Buy
900
+200
+29% +$113K ﹤0.01% 377
2025
Q3 		$340K Buy
700
+200
+40% +$93.1K ﹤0.01% 505
2025
Q2 		$203K Hold
500
– – ﹤0.01% 373
2025
Q1 		$249K Buy
+500
New +$271K ﹤0.01% 459
2024
Q4 		– Sell
-400
Closed -$247K – 598
2024
Q3 		$247K Sell
400
-400
-50% -$237K ﹤0.01% 344
2024
Q2 		$442K Buy
+800
New +$458K ﹤0.01% 256
2023
Q4 		– Sell
-1,400
Closed -$709K – 566
2023
Q3 		$709K Buy
+1,400
New +$746K 0.01% 284
2023
Q2 		– Sell
-52,900
Closed -$30.5M – 773
2023
Q1 		$30.5M Buy
52,900
+33,400
+171% +$18.8M 0.37% 56
2022
Q4 		$10.7M Sell
19,500
-9,400
-33% -$4.98M 0.14% 174
2022
Q3 		$14.7M Buy
+28,900
New +$16.2M 0.2% 138
2020
Q3 		– Sell
-6,400
Closed -$2.32M – 297
2020
Q2 		$2.32M Buy
+6,400
New +$2.15M 0.08% 195

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capula Management's TMO Position: Q2 2026 in Review

Capula Management reduced its Thermo Fisher Scientific (TMO) stake by 5.9% in Q2 2026, selling an estimated $5.28K and leaving 177 shares worth $88.7K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Capula Management first reported a position in TMO in Q1 2021 and has held it in 14 quarters since. The position peaked at $4.36M in Q2 2022. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capula Management held 177 shares of Thermo Fisher Scientific worth $88.7K as of Q2 2026.
  • Capula Management sold 11 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.28K.
  • Thermo Fisher Scientific made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #619 holding.
  • Capula Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 14 quarters since.
  • Capula Management's Thermo Fisher Scientific position peaked at $4.36M in Q2 2022.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.